Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus

Lupus

Volumn 19, Issue 7, 2010, Pages 850-859

  Nie, Y ^a   Lau, C S ^a   Lie, A K W ^a   Chan, G C F ^a   Mok, M Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Autoimmune disease; Mesenchymal stem cells; Systemic lupus erythematosus; Telomerase

Indexed keywords

5' NUCLEOTIDASE; AZATHIOPRINE; BETA1 INTEGRIN; ENDOGLIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TELOMERASE; THY 1 ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOGENESIS; ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE DEVELOPMENT; BONE MARROW BIOPSY; CALCIFICATION; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; OSTEOBLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

5'-NUCLEOTIDASE; ANTIGENS, CD; ANTIGENS, THY-1; CASE-CONTROL STUDIES; CELL AGING; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MESENCHYMAL STEM CELLS; PHENOTYPE; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; TELOMERASE;

EID: 77952921223     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309361482     Document Type: Article

References (35)

1. Tavassoli M., Friedenstein A. Hemopoietic stromal microenvironment. Am J Hematol 1983 ; 15: 195-203.
2. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999 ; 284: 143-147.
3. Wakitani S., Saito T., Caplan AI Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995 ; 18: 1417-1426.
4. Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., Verfaillie CM Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001 ; 98: 2615-2625.
5. Prockop DJ Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997 ; 276: 71-74.
6. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002 ; 30: 42-48.
7. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 ; 99: 3838-3843.
8. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004 ; 363: 1439-1441.
9. Lampeter EF, McCann SR, Kolb H. Transfer of diabetes type 1 by bone-marrow transplantation. Lancet 1998 ; 351: 568-569.
10. Kishimoto Y., Yamamoto Y., Ito T., et al. Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997 ; 19: 1041-1043.
11. Burt RK, Slavin S., Burns WH, Marmont AM Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 2002 ; 99: 768-784.
12. El-Badri NS, Hakki A., Ferrari A., Shamekh R., Good RA Autoimmune disease: is it a disorder of the microenvironment? Immunol Res 2008 ; 41: 79-86.
13. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 1725.
14. Bombardier C., Gladman DD, Urowitz MB, Caron D., Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992 ; 35: 630-640.
15. Lennon DP, Caplan AI Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol 2006 ; 34: 1604-1605.
16. Zakian VA Telomeres: beginning to understand the end. Science 1995 ; 270: 1601-1607.
17. Klapper W., Moosig F., Sotnikova A., Qian W., Schroder JO, Parwaresch R. Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 2004 ; 63: 1681-1683.
18. Colter DC, Sekiya I., Prockop DJ Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 2001 ; 98: 7841-7845. (Pubitemid 32642648)
19. Bruder SP, Jaiswal N., Haynesworth SE Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997 ; 64: 278-294.
20. Stenderup K., Justesen J., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003 ; 33: 919-926.
21. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004 ; 22: 675-682.
22. Ross SE, Hemati N., Longo KA, et al. Inhibition of adipogenesis by Wnt signaling. Science 2000 ; 289: 950-953.
23. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994 ; 266: 2011-2015.
24. Hiyama K., Hirai Y., Kyoizumi S., et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995 ; 155: 3711-3715.
25. Zimmermann S., Voss M., Kaiser S., Kapp U., Waller CF, Martens UM Lack of telomerase activity in human mesenchymal stem cells. Leukemia 2003 ; 17: 1146-1149.
26. Sethe S., Scutt A., Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev 2006 ; 5: 91-116.
27. Kurosaka D., Yasuda J., Yoshida K., et al. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus. J Rheumatol 2006 ; 33: 1102-1107.
28. Ohtsuka T., Yamakage A., Yamazaki S. The polymorphism of telomerase RNA component gene in patients with systemic sclerosis. Br J Dermatol 2002 ; 147: 250-254.
29. Bocelli-Tyndall C., Bracci L., Spagnoli G., et al. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology (Oxford) 2007 ; 46: 403-408.
30. Krampera M., Glennie S., Dyson J., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003 ; 101: 3722-3729.
31. Sun LY, Zhang HY, Feng XB, Hou YY, Lu LW, Fan LM Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 2007 ; 16: 121-128.
32. Dominici M., Paolucci P., Conte P., Horwitz EM Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation 2009 ; 87 (9 Suppl). S36 - S42.
33. Buron F., Perrin H., Malcus C., et al. Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells. Transplant Proc 2009 ; 41: 3347-3352.
34. van Laar JM, Tyndall A. Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford) 2006 ; 45: 1187-1193.
35. Cahill RA, Jones OY, Klemperer M., et al. Replacement of recipient stromal/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells. Biol Blood Marrow Transplant 2004 ; 10: 709-717.